MICHAEL BEARD: Open Payments
NPI 1316949167 · BENTON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$884 in 33 payments from 9 companies in 2025. Trend: 2023 $1,703 · 2024 $816 · 2025 $884
Food & beverage: $884
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $357 |
| AstraZeneca Pharmaceuticals LP | 3 | $300 |
| ABBVIE INC. | 3 | $66 |
| Phathom Pharmaceuticals, Inc. | 3 | $57 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| Exact Sciences Corporation | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: BRILINTA, Wegovy, Rybelsus, Ozempic, VOQUEZNA, UBRELVY, QULIPTA, FARXIGA.
Industry payments across AR — which companies pay providers there.
